Champions Oncology, Inc. (CSBR)
4.99
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 16:00
4.99
0.00 (0.00%)
After-Hours: 19:47
Champions Oncology Total Long Term Debt (Quarterly) : 3.078M for April 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 3.078M |
| January 31, 2026 | 3.47M |
| October 31, 2025 | 3.887M |
| July 31, 2025 | 4.426M |
| April 30, 2025 | 4.854M |
| January 31, 2025 | 5.261M |
| October 31, 2024 | 5.668M |
| July 31, 2024 | 6.071M |
| April 30, 2024 | 6.093M |
| January 31, 2024 | 6.437M |
| October 31, 2023 | 6.775M |
| July 31, 2023 | 7.107M |
| April 30, 2023 | 7.391M |
| January 31, 2023 | 7.702M |
| October 31, 2022 | 7.832M |
| July 31, 2022 | 8.127M |
| April 30, 2022 | 8.412M |
| January 31, 2022 | 8.618M |
| October 31, 2021 | 8.525M |
| July 31, 2021 | 8.652M |
| April 30, 2021 | 8.783M |
| January 31, 2021 | 5.798M |
| October 31, 2020 | 5.95M |
| July 31, 2020 | 6.116M |
| April 30, 2020 | 3.295M |
| Date | Value |
|---|---|
| January 31, 2020 | 3.478M |
| October 31, 2019 | 3.431M |
| July 31, 2019 | 3.562M |
| April 30, 2019 | 0.016M |
| January 31, 2019 | 0.224M |
| October 31, 2018 | 0.237M |
| July 31, 2018 | 0.285M |
| April 30, 2018 | 0.042M |
| January 31, 2018 | 0.049M |
| October 31, 2017 | 0.055M |
| July 31, 2017 | 0.058M |
| April 30, 2017 | 0.063M |
| January 31, 2017 | 0.068M |
| October 31, 2016 | 0.073M |
| July 31, 2016 | 0.078M |
| April 30, 2016 | 0.083M |
| January 31, 2016 | 0.00 |
| October 31, 2015 | 0.00 |
| July 31, 2015 | 0.00 |
| April 30, 2015 | 0.00 |
| January 31, 2015 | 0.00 |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 0.00 |
| April 30, 2014 | 0.00 |
| January 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 120.10M |
| Avantor, Inc. | 3.698B |
| Personalis, Inc. | 31.06M |
| Adaptive Biotechnologies Corp. | 401.68M |
| 10X Genomics, Inc. | 66.78M |